Zhao Lin, Zhang Xiaoran, Meng Xu, Zhang Ting, Fan Hua, Zhang Qiongyu, Liu Yecheng, Zhou Xianliang, Zhu Huadong
Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China.
Department of Emergency Medicine, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China.
J Clin Med. 2022 Sep 23;11(19):5583. doi: 10.3390/jcm11195583.
Pheochromocytomas and paragangliomas (PPGLs) associated with negative catecholamines are not uncommon. However, few studies have examined clinical features of patients with these tumors. In the absence of available data, it is difficult to identify characteristics of patients with potential PPGLs and normal serum and urine screens. Therefore, an analysis of patients with PPGLs was conducted retrospectively to compare the clinical features of patients with positive and negative catecholamines. This study included 214 patients, including 69 patients with negative catecholamines. Prevalence rates of diabetes (p < 0.001) and hypertension (p < 0.001) were lower and tumor diameter (p < 0.001) was smaller in the negative-catecholamine group compared with the positive-catecholamine group. Multivariable logistic regression analysis showed that extra-adrenal PPGLs were independently positively associated with negative catecholamines (p = 0.004); hypertension (p = 0.001) and tumor diameter (p = 0.016) were independently negatively associated with negative catecholamines. There was no significant difference in tumor recurrence between the two groups (mean follow-up, 20.54 ± 11.83 months) (p = 0.44). The results demonstrated that PPGL patients with negative catecholamines were more likely to have extra-adrenal tumors and less likely to have comorbidities, and these patients should also be closely monitored for tumor recurrence.
与儿茶酚胺阴性相关的嗜铬细胞瘤和副神经节瘤(PPGLs)并不少见。然而,很少有研究探讨这些肿瘤患者的临床特征。在缺乏可用数据的情况下,很难识别潜在PPGLs且血清和尿液筛查正常的患者的特征。因此,对PPGLs患者进行了回顾性分析,以比较儿茶酚胺阳性和阴性患者的临床特征。本研究纳入了214例患者,其中69例儿茶酚胺阴性。与儿茶酚胺阳性组相比,儿茶酚胺阴性组的糖尿病患病率(p < 0.001)和高血压患病率(p < 0.001)较低,肿瘤直径(p < 0.001)较小。多变量逻辑回归分析显示,肾上腺外PPGLs与儿茶酚胺阴性独立正相关(p = 0.004);高血压(p = 0.001)和肿瘤直径(p = 0.016)与儿茶酚胺阴性独立负相关。两组间肿瘤复发无显著差异(平均随访20.54 ± 11.83个月)(p = 0.44)。结果表明,儿茶酚胺阴性的PPGL患者更易发生肾上腺外肿瘤,合并症较少,这些患者也应密切监测肿瘤复发情况。